Cigna lobbying spend hits $60,000 as CI trades 18% below target
Alpha Vantage · Quiver Quantitative · · AI-summarised by FinFlash
THE CIGNA GROUP AND SUBSIDIARIES (CI) recently disclosed $60,000 in lobbying expenditures for Q3 2026, focusing on federal tax and healthcare issues. Insider trading data shows primarily sales by executives, while institutional investors had mixed activity, with some adding and others reducing their positions. Analysts have set a median price target of $338.0 for CI, based on recent assessments.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.